Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1990-10-4
|
pubmed:abstractText |
To enhance the intrinsic potency of dihydropyrimidine calcium channel blockers, we have modified the structure of previously described 2-heteroalkyl-1,4-dihydropyrimidines 2 to 3-substituted 1,4-dihydropyrimidines 3. Structure-activity studies using potassium-depolarized rabbit aorta show that ortho, meta-disubstituted aryl derivatives are more potent than either ortho- or meta-monosubstituted compounds. While vasorelaxant activity was critically dependent on the size of the C5 ester group, isopropyl ester being the best, a variety of substituents (carbamate, acyl, sulfonyl, alkyl) were tolerated at N3. Our results show dihydropyrimidines 3 are significantly more potent than corresponding 2-heteroalkyl-1,4-dihydropyrimidines 2 and only slightly less potent than similarly substituted 2-heteroalkyl-1,4-dihydropyridines 4 and 5. Whereas dihydropyridine enantiomers usually show 10-15-fold difference in activity, the enantiomers of dihydropyrimidine 3j show more than a 1000-fold difference in activity. These results strengthen the requirement of an enamino ester for binding to the dihydropyridine receptor and indicate a nonspecific role for the N3-substituent.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2629-35
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2391701-Animals,
pubmed-meshheading:2391701-Calcium Channel Blockers,
pubmed-meshheading:2391701-Chemical Phenomena,
pubmed-meshheading:2391701-Chemistry,
pubmed-meshheading:2391701-Dihydropyridines,
pubmed-meshheading:2391701-Male,
pubmed-meshheading:2391701-Muscle, Smooth, Vascular,
pubmed-meshheading:2391701-Pyrimidines,
pubmed-meshheading:2391701-Rabbits,
pubmed-meshheading:2391701-Rats,
pubmed-meshheading:2391701-Rats, Inbred Strains,
pubmed-meshheading:2391701-Structure-Activity Relationship
|
pubmed:year |
1990
|
pubmed:articleTitle |
Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.
|
pubmed:affiliation |
Squibb Institute for Medical Research, Princeton, New Jersey 08543-4000.
|
pubmed:publicationType |
Journal Article
|